Related Experiment Videos
Biologic response to hydroxylapatite-coated titanium hips. A preliminary study in dogs
K A Thomas1, S D Cook, R J Haddad
1Department of Orthopaedic Surgery, Tulane University School of Medicine, New Orleans, LA 70112.
The Journal of Arthroplasty
|January 1, 1989
Summary
Hydroxylapatite (HA) coating on Ti-6A1-4V femoral implants significantly enhances bone apposition and integration compared to uncoated implants. HA coatings promote early bone growth and stability without degradation over 52 weeks.
Area of Science:
- Biomaterials Science
- Orthopedic Surgery
- Veterinary Medicine
Background:
- Ti-6A1-4V alloy is a common material for femoral endoprostheses.
- Bone ingrowth and implant stability are critical for successful joint replacement.
- Hydroxylapatite (HA) coating is investigated to improve osseointegration.
Purpose of the Study:
- To evaluate the effect of HA coating on Ti-6A1-4V femoral endoprostheses in a canine model.
- To compare bone apposition and implant stability between HA-coated and uncoated implants with porous or grooved surfaces.
Main Methods:
- Adult dogs (n=12) received unilateral hemiarthroplasties with HA-coated or uncoated Ti-6A1-4V femoral stems.
- Implants featured porous titanium or grooved macrotexture with or without HA coating.
- Histological analysis was performed at intervals up to 52 weeks.
Main Results:
- HA-coated grooved implants showed extensive direct bone apposition by 5 weeks; uncoated grooved implants showed none by 10 weeks.
- Bone ingrowth in uncoated porous implants was similar to HA-coated porous implants by 6-10 weeks.
- All HA-coated implants exhibited consistent bone apposition without fibrous tissue, and no coating deterioration or separation was observed.
Conclusions:
- Hydroxylapatite coating significantly enhances early bone apposition and integration of Ti-6A1-4V femoral implants.
- HA coating promotes a stable, well-integrated implant interface without compromising coating integrity.
- These findings support the use of HA coatings to improve outcomes in femoral endoprostheses.